Ames Constance Insider Trades

Insider Trading History

Track insider trading activity for Ames Constance. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Axsome Therapeutics
Axsome Therapeutics AXSM
Vice President, Finance
Holding Value $5.84M 25,000 shares
Last Trade
Mar 15, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$124k 25,000 shares
$4.95
$233.49
Axsome Therapeutics
Axsome Therapeutics AXSM
Vice President, Finance
Holding Value $5.84M 25,000 shares
Last Trade
May 27, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$201k 25,000 shares
$8.02
$233.49
Axsome Therapeutics
Axsome Therapeutics AXSM
Vice President, Finance
Holding Value $0 0 shares
Last Trade
Nov 24, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.1k 4,358 shares
$9.20
$233.49
Axsome Therapeutics
Axsome Therapeutics AXSM
Vice President, Finance
Holding Value $1.02M 4,358 shares
Last Trade
Nov 24, 2015 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$40.1k 4,358 shares
$9.20
$233.49
Axsome Therapeutics
Axsome Therapeutics AXSM
Vice President, Finance
Holding Value $9.5M 40,673 shares
Last Trade
Nov 19, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$355k 40,673 shares
$8.74
$233.49
Axsome Therapeutics
Axsome Therapeutics AXSM
Vice President, Finance
Holding Value $0 0 shares
Last Trade
Nov 19, 2015 Sale
$340k 38,925 shares
$8.74
$233.49
Axsome Therapeutics
Axsome Therapeutics AXSM
Vice President, Finance
Holding Value $0 0 shares
Last Trade
Jun 16, 2015 Sale
No data
No data
$233.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up